
Mehdi Touat
@MTouatMD
Followers
409
Following
747
Media
8
Statuses
508
Neuro-oncologist @HopPitieSalpe @APHP @Sorbonne_Univ_ & @ParisBrainInst working on brain tumors
Paris
Joined June 2016
RT @junyue_cao: Finally out in @ScienceMagazine! Utilizing the cost-effective EasySci to profile 21 million single-cell transcriptomes acro….
0
60
0
RT @yujungche: I’m excited to share our latest study in @nature on this novel compound called Gliocidin, that targets glioblastoma (#GBM),….
nature.com
Nature - The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.
0
81
0
RT @NathansonLab: Check out our latest paper integrating genomic and functional precision medicine to identify therapeutic vulnerabilities….
nature.com
Nature Communications - Genomic profiling of tumours can help tailer treatments to the patient, however, it often fails to accurately predict therapeutic outcomes. Here, the authors combine...
0
7
0
RT @jakeyoung11: Incredible team effort on this translational project - just in time for SNO! Longitudinal multimodal profiling of IDH-wild….
academic.oup.com
AbstractBackground. Despite recent advances in the biology of IDH-wildtype glioblastoma, it remains a devastating disease with median survival of less than
0
10
0
RT @jingyi_wu_bio: Our work reveals that as IDH mutant gliomas progress, their cell states and key drivers change.
nature.com
Nature Cancer - Wu et al. perform single-cell analyses to explore the switch from low-grade to high-grade isocitrate-dehydrogenase-mutant glioma and show that it is characterized by oligodendrocyte...
0
32
0
RT @michelle_monje: #CARTcells for #DIPG #DMG clinical trial (1st arm) results are out today. Full Tweetorial coming, but first want to sha….
0
160
0
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas | Nature
nature.com
Nature - We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M+ diffuse midline glioma (DMG), finding that intravenous administration of...
0
2
16
RT @EricTopol: One of the major challenges in human genomics is the functional assessment of variants. Base and prime #CRISPR genome editin….
nature.com
Nature Biotechnology - Thousands of rare oncogene variants are evaluated using multimodal gene editing screens.
0
40
0
Enhancing transcription–replication conflict targets ecDNA-positive cancers | Nature
nature.com
Nature - Extrachromosomal DNA makes cancerous tumours resistant to treatment, but this research demonstrates that increasing transcription–replication conflict allows for targeted elimination...
0
0
1
RT @CharlesSwanton: ecDNA are rogue genetic material that amplify genes, contribute to treatment resistance and drive genomic heterogeneity….
0
187
0
RT @CancerGrand: Today #CancerGrandChallenges team eDyNAmiC and their international collaborators published 3️⃣ papers in.@Nature 📣. They s….
0
35
0
RT @Aiims1742: First of a series of papers from the @NCIHTAN is out in @Nature this morning. Tumour evolution and microenvironment interac….
0
83
0
RT @rborza_: 🚨 Great alternatives to BioRender are now available!!. 📢 @NIAIDNews offers a collection of public figures and icons for everyo….
0
643
0
RT @Aiims1742: Because ONE spatial profiling technology is not enough!.New paper by @Nikhilwagle in @NatureMedicine .A multi-modal single-c….
0
27
0
RT @mitchkim_mw: Transforming traditional views laid by “CNS immune privilege,” our research uncovers the brain’s purposeful presentation….
nature.com
Nature - Central nervous system (CNS)-derived regulatory self-peptides are essential for maintaining a continuous dialogue between the CNS and the immune system while balancing overt autoreactivity.
0
72
0
RT @Aiims1742: Huge congratulations to @KarunaMDPhD for this important study out in @Nature .Progressive plasticity during colorectal cance….
0
43
0
RT @RajKhajur: IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation.
biorxiv.org
Discovering the cell-of-origin harboring the initial driver mutation provides a fundamental basis for understanding tumor evolution and development of new treatments. For isocitrate dehydrogenase...
0
6
0